Patel, M. N., Taylor, A. O., Branchaud, B., Campbell, D., Kramer, A. N., Herring, K. W., … LeBlanc, T. W. (2024). Treatment Experience of Patients with Acute Myeloid Leukemia in the Era of Novel Therapies: A Longitudinal Electronic Patient-Reported Outcomes Study. In Blood (Vol. 144, pp. 2422–2422). American Society of Hematology. https://doi.org/10.1182/blood-2024-193842

Patel, Mihir N., Allison O. Taylor, Brenda Branchaud, David Campbell, Anneli N. Kramer, Kris W. Herring, Jesse D. Troy, and Thomas W. LeBlanc. “Treatment Experience of Patients with Acute Myeloid Leukemia in the Era of Novel Therapies: A Longitudinal Electronic Patient-Reported Outcomes Study.” In Blood, 144:2422–2422. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-193842.

Patel MN, Taylor AO, Branchaud B, Campbell D, Kramer AN, Herring KW, et al. Treatment Experience of Patients with Acute Myeloid Leukemia in the Era of Novel Therapies: A Longitudinal Electronic Patient-Reported Outcomes Study. In: Blood. American Society of Hematology; 2024. p. 2422–2422.

Patel, Mihir N., et al. “Treatment Experience of Patients with Acute Myeloid Leukemia in the Era of Novel Therapies: A Longitudinal Electronic Patient-Reported Outcomes Study.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 2422–2422. Crossref, doi:10.1182/blood-2024-193842.

Patel MN, Taylor AO, Branchaud B, Campbell D, Kramer AN, Herring KW, Troy JD, LeBlanc TW. Treatment Experience of Patients with Acute Myeloid Leukemia in the Era of Novel Therapies: A Longitudinal Electronic Patient-Reported Outcomes Study. Blood. American Society of Hematology; 2024. p. 2422–2422.